Related references
Note: Only part of the references are listed.Propofol Related Infusion Syndrome: Ultrastructural Evidence for a Mitochondrial Disorder
Jorg-Peter Vollmer et al.
CRITICAL CARE MEDICINE (2018)
Mitochondrial respiratory gene expression is suppressed in many cancers
Ed Reznik et al.
ELIFE (2017)
Phase I Safety, Pharmacokinetic, and Pharmacodynamic Study of the Poly(ADP-ribose) Polymerase (PARP) Inhibitor Veliparib (ABT-888) in Combination with Irinotecan in Patients with Advanced Solid Tumors
Patricia M. LoRusso et al.
CLINICAL CANCER RESEARCH (2016)
Mitochondrial DNA copy number variation across human cancers
Ed Reznik et al.
ELIFE (2016)
Mechanistic review of drug-induced steatohepatitis
Justin D. Schumacher et al.
TOXICOLOGY AND APPLIED PHARMACOLOGY (2015)
Methods for Detection of Mitochondrial and Cellular Reactive Oxygen Species
Sergey I. Dikalov et al.
ANTIOXIDANTS & REDOX SIGNALING (2014)
Circulating acylcarnitines as biomarkers of mitochondrial dysfunction after acetaminophen overdose in mice and humans
Mitchell R. McGill et al.
ARCHIVES OF TOXICOLOGY (2014)
Pharmacometabolomics: Implications for Clinical Pharmacology and Systems Pharmacology
R. Kaddurah-Daouk et al.
CLINICAL PHARMACOLOGY & THERAPEUTICS (2014)
Purine Pathway Implicated in Mechanism of Resistance to Aspirin Therapy: Pharmacometabolomics-Informed Pharmacogenomics
L. M. Yerges-Armstrong et al.
CLINICAL PHARMACOLOGY & THERAPEUTICS (2013)
Chemotherapy induced hepatotoxicity in metastatic colorectal cancer: A review of mechanisms and outcomes
Derek McWhirter et al.
CRITICAL REVIEWS IN ONCOLOGY HEMATOLOGY (2013)
Oxidative stress induces DNA demethylation and histone acetylation in SH-SY5Y cells: potential epigenetic mechanisms in gene transcription in Aβ production
Xinling Gu et al.
NEUROBIOLOGY OF AGING (2013)
Acylcarnitine Profiles in Acetaminophen Toxicity in the Mouse: Comparison to Toxicity, Metabolism and Hepatocyte Regeneration
Sudeepa Bhattacharyya et al.
METABOLITES (2013)
A positive/negative ion-switching, targeted mass spectrometry-based metabolomics platform for bodily fluids, cells, and fresh and fixed tissue
Min Yuan et al.
NATURE PROTOCOLS (2012)
Metabolomics Reveals Amino Acids Contribute to Variation in Response to Simvastatin Treatment
Miles Trupp et al.
PLOS ONE (2012)
Mitochondrial Roles and Cytoprotection in Chronic Liver Injury
Davide Degli Esposti et al.
BIOCHEMISTRY RESEARCH INTERNATIONAL (2012)
Fermented Barley Extract Supplementation Maintained Antioxidative Defense Suppressing Lipopolysaccharide-Induced Inflammatory Liver Injury in Rats
Puspo E. Giriwono et al.
BIOSCIENCE BIOTECHNOLOGY AND BIOCHEMISTRY (2011)
Pharmacometabonomic Profiling as a Predictor of Toxicity in Patients with Inoperable Colorectal Cancer Treated with Capecitabine
Alexandra Backshall et al.
CLINICAL CANCER RESEARCH (2011)
Drug-induced toxicity on mitochondria and lipid metabolism: Mechanistic diversity and deleterious consequences for the liver
Karima Begriche et al.
JOURNAL OF HEPATOLOGY (2011)
Amine Metabolomics of Hyperglycemic Endothelial Cells using Capillary LC-MS with Isobaric Tagging
Wei Yuan et al.
JOURNAL OF PROTEOME RESEARCH (2011)
C. elegans metallothioneins: response to and defence against ROS toxicity
Sukaina Zeitoun-Ghandour et al.
MOLECULAR BIOSYSTEMS (2011)
Use of Pharmaco-Metabonomics for Early Prediction of Acetaminophen-Induced Hepatotoxicity in Humans
J. H. Winnike et al.
CLINICAL PHARMACOLOGY & THERAPEUTICS (2010)
An Integrative Approach for Identifying a Metabolic Phenotype Predictive of Individualized Pharmacokinetics of Tacrolimus
P. B. Phapale et al.
CLINICAL PHARMACOLOGY & THERAPEUTICS (2010)
Hepatic Toxicities Associated with the Use of Preoperative Systemic Therapy in Patients with Metastatic Colorectal Adenocarcinoma to the Liver
James M. Cleary et al.
ONCOLOGIST (2009)
The effect of rosiglitazone on asymmetric dimethylarginine (ADMA) in critically ill patients
M. C. Richir et al.
PHARMACOLOGICAL RESEARCH (2009)
Pharmacometabonomic identification of a significant host-microbiome metabolic interaction affecting human drug metabolism
T. Andrew Clayton et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2009)
Aging, diabetes, and renal failure catalyze the oxidation of lysyl residues to 2-aminoadipic acid in human skin collagen - Evidence for metal-catalyzed oxidation mediated by alpha-dicarbonyls
David R. Sell et al.
MAILLARD REACTION: RECENT ADVANCES IN FOOD AND BIOMEDICAL SCIENCES (2008)
Metabolomics: A global biochemical approach to drug response and disease
Rima Kaddurah-Daouk et al.
ANNUAL REVIEW OF PHARMACOLOGY AND TOXICOLOGY (2008)
Drug-induced liver injury through mitochondrial dysfunction: mechanisms and detection during preclinical safety studies
Gilles Labbe et al.
FUNDAMENTAL & CLINICAL PHARMACOLOGY (2008)
Capecitabine and irinotecan as first-line treatment of advanced colorectal cancer
Cornelis J. A. Punt et al.
JOURNAL OF CLINICAL ONCOLOGY (2008)
Mitochondrial involvement in non-alcoholic steatohepatitis
Gaetano Serviddio et al.
MOLECULAR ASPECTS OF MEDICINE (2008)
2-Aminoadipic acid is a marker of protein carbonyl oxidation in the aging human skin: effects of diabetes, renal failure and sepsis
David R. Sell et al.
BIOCHEMICAL JOURNAL (2007)
Inflammation is an important determinant of levels of the endogenous nitric oxide synthase inhibitor asymmetric dimethylarginine (ADMA) in acute liver failure
Rajeshwar P. Mookerjee et al.
LIVER TRANSPLANTATION (2007)
Increasing dimethylarginine levels are associated with adverse clinical outcome in severe alcoholic hepatitis
Rajeshwar P. Mookerjee et al.
HEPATOLOGY (2007)
Chemotherapy regimen predicts steatohepatitis and an increase in 90-day mortality after surgery for hepatic colorectal metastases
JN Vauthey et al.
JOURNAL OF CLINICAL ONCOLOGY (2006)
Lysophosphatidylcholine-induced elevation of asymmetric dimethylarginine level by the NADPH oxidase pathway in endothelial cells
SJ Jia et al.
VASCULAR PHARMACOLOGY (2006)
Mitochondrial dysfunction in NASH: Causes, consequences and possible means to prevent it
K Begriche et al.
MITOCHONDRION (2006)
Redox regulation and reaction mechanism of human cystathionine-beta-synthase: a PLP-dependent hemesensor protein
R Banerjee et al.
ARCHIVES OF BIOCHEMISTRY AND BIOPHYSICS (2005)
The ins and outs of mitochondrial dysfunction in NASH
B Fromenty et al.
DIABETES & METABOLISM (2004)
Cardiovascular biology of the asymmetric dimethylarginine: Dimethylarginine dimethylaminohydrolase pathway
P Vallance et al.
ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY (2004)
Tandem mass spectrometric determination of malonyl-carnitine:: Diagnosis and neonatal screening of malonyl-CoA decarboxylase deficiency
R Santer et al.
CLINICAL CHEMISTRY (2003)
Histone acetylation regulates epithelial IL-8 release mediated by oxidative stress from environmental particles
PS Gilmour et al.
AMERICAN JOURNAL OF PHYSIOLOGY-LUNG CELLULAR AND MOLECULAR PHYSIOLOGY (2003)
The effect of oxidative stress on histone acetylation and IL-8 release
K Tomita et al.
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS (2003)
The liver is an important organ in the metabolism of asymmetrical dimethylarginine (ADMA)
RJ Nijveldt et al.
CLINICAL NUTRITION (2003)
S-nitrosylation of dimethylarginine dimethylaminohydrolase regulates enzyme activity:: Further interactions between nitric oxide synthase and dimethylarginine dimethylaminohydrolase
J Leiper et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2002)
Human cystathionine β-synthase is a heme sensor protein.: evidence that the redox sensor is heme and not the vicinal cysteines in the CXXC motif seen in the crystal structure of the truncated enzyme
S Taoka et al.
BIOCHEMISTRY (2002)
State of the Arg: Protein methylation at arginine comes of age
AE McBride et al.
CELL (2001)
Impaired fatty acid oxidation in propofol infusion syndrome
A Wolf et al.
LANCET (2001)
The quantitatively important relationship between homocysteine metabolism and glutathione synthesis by the transsulfuration pathway and its regulation by redox changes
E Mosharov et al.
BIOCHEMISTRY (2000)
Irinotecan plus fluorouracil and leucovorin for metastatic colorectal cancer.
LB Saltz et al.
NEW ENGLAND JOURNAL OF MEDICINE (2000)
Share Paper
